In patients with gastric cancer (GC), IL-6 and IL-8 activate CD45+CD33lowCD11bdim MDSCs, thereby inducing Arg1 release accompanied by activation of the PI3K-AKT signaling pathway. Here, ARG1 is linked to gastric cancer.